Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07263321

Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.

The goal of this clinical trial is to compare three different treatments for depression in patients with moderate depression in General Practice, aged 18-65 years.

We wish to investigate the effect of the treatment approaches, and 171 patients will be included in the trial. The participants will be randomised to one of the following three treatments:

1. Standard treatment provided by a general practitioner (i.e. the general practitioner treats the patient as he/she would normally do, when treating a patient with depression). 2. Standard treatment provided by a psychologist in the form behavioural therapy (i.e. the psychologist treats the patient as he/she would normally do, when treating a patient with depression). 3. A step-by-step treatment plan carried out by a general practitioner. The plan includes pre-determined follow-ups and a pre-determined, structured plan for which medications to use and when to increase dose or switch medication.

The hypothesis is that a structured and step-by-step treatment approach regarding patients with depression, treated in general practice, is more effective than standard treatment provided by a general practitioner and a psychologist.

All the participants will:

1. Receive one of the three treatments for 12 weeks. 2. Have meetings with the project staff every 4 weeks (week 0, 4, 8 and 12) were rating scales will be completed, e.g. a rating scale to measure progress or deterioration in the participant's depression.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aalborg University Hospital, Department of Psychiatry

Aalborg, Denmark

Location status: Recruiting

Location contact

Sarah Bloch

CONTACT

[email protected]

0045 40196342

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The participant must be referred to the study with a diagnosis of unipolar depressive disorder, as judge by the GP.
  • Severity of the depressive episode corresponding to moderate depression, as judged by the GP.
  • Clinical uncertainty regarding which of the treatments, medication or psychotherapy, would be the better choice in the case concerned.
  • Age criteria: Participants must be at least 18 years old and no more than 65 years old at the time of randomisation.
  • The participant must be a patient in general practice.
  • Participants must be able to participate in virtual meetings (e.g. by phone or computer) and have e-Boks.
  • The participant must be willing to receive psychotherapy by a psychologist and/or medication.
  • Must have signed the document of informed consent.

Exclusion criteria

  • Misuse of substances that might influence the study, as judged by the investigator.
  • Difficulty in understanding the Danish language, as judged by the investigator.
  • A diagnosis of dementia.
  • Medical conditions that might interfere with the study outcome or safety, judged so by the investigator.
  • Pregnancy.
  • High risk of non-adherence at the investigator's discretion.
  • Suicidality: according to C-SSRS with a positive response to question 4 or 5 within the last three months or upon investigator's discretion.
  • No current medical or psychotherapy treatment initiated within the last 4 weeks prior to screening.

Treatment and study plan

Algorithm-Based Treatment

Other

This is an open-label pharmacological intervention.

Other names: ALGO, Algorithm-guided treatment, Algorithm treatment

Treatment as usual (TAU)

Other

This is a "treatment as usual" provided by a general practitioner (GP). The GP will implement a standard treatment he or she normally would use, when treating a patient with moderate depression in general practice.

Other names: Treatment as usual by a general practitioner, TAU-GP

Primary outcomes

  1. The Hamilton Rating Scale for Depression, 6 item version (HAM-D6)

    Time frame: From enrollment to the end of treatment at 12 weeks.

Secondary outcomes

  1. The Columbia-Suicide Severity Rating Scale (C-SSRS)

    Time frame: From enrollment to the end of treatment at 12 weeks.

  2. The Major Depression Inventory (MDI)

    Time frame: From enrollment to the end of treatment at 12 weeks.

  3. The Personal and Social Performance Scale (PSP)

    Time frame: From enrollment to the end of treatment at 12 weeks

  4. The Danish Adult Reading Test (DART)

    Time frame: At enrollment

  5. The Brief INSPIRE-O

    Time frame: At the end of the treatment at 12 weeks.

Study contacts

Contact information is provided by the study sponsor or research team.

Sarah Bloch, MD and PhD student

CONTACT

[email protected]

0045 40196342

Sponsors and collaborators

Lead sponsor

Aalborg University Hospital

Other

Registry information

Official study title

Optimising Treatment for Patients With Depressive Episodes in General Practice Through Algorithm-Based Treatment: A Randomised, Open-label Controlled Trial.

Acronym: ODEGA

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Dec 4, 2025
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.